Answers are grounded in this paper and cite their sources.
Because of the fundamental importance of new therapeutic routes for cancer treatment, a number of systems based on colloidal particles as vehicles for the delivery of the anticancer drug 5-fluorouracil have been devised. The target is always to provide the proper dose of the antitumor agent only at the desired locus of action, thus reducing the unwanted side effects. In this review, the main strategies and the more significant results in the development of 5-fluorouracil carriers for cancer treatment are discussed.
No takes yet. Share an insight, caveat, or question.
José L. Arias (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: